US FDA sets 30 June deadline for finalising companion diagnostics guidance; publishes other device priorities
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration's guideline on the development of companion diagnostics is expected to be finalised by 30 June, the agency has announced in a document outlining its medical device unit's strategic priorities for 20121.